Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 169

1.

Efficacy of a tailored PCR-guided triple therapy in the treatment of Helicobacter pylori infection.

Delchier JC, Bastuji-Garin S, Raymond J, Megraud F, Amiot A, Cambau E, Burucoa C; HELICOSTIC Study Group.

Med Mal Infect. 2019 Jun 27. pii: S0399-077X(18)30185-9. doi: 10.1016/j.medmal.2019.06.001. [Epub ahead of print]

PMID:
31257067
2.

Long-term course of precancerous lesions arising in patients with gastric MALT lymphoma.

Rentien AL, Lévy M, Copie-Bergman C, Gagniere C, Dupuis J, Le Baleur Y, Belhadj K, Sobhani I, Haioun C, Delchier JC, Amiot A.

Dig Liver Dis. 2018 Feb;50(2):181-188. doi: 10.1016/j.dld.2017.10.014. Epub 2017 Oct 27.

PMID:
29102522
3.

Helicobacter pylori, gastric cancer and other gastrointestinal malignancies.

Venerito M, Vasapolli R, Rokkas T, Delchier JC, Malfertheiner P.

Helicobacter. 2017 Sep;22 Suppl 1. doi: 10.1111/hel.12413. Review.

PMID:
28891127
4.

Second primary malignancies in patients treated for gastric mucosa-associated lymphoid tissue lymphoma.

Amiot A, Jooste V, Gagniere C, Lévy M, Copie-Bergman C, Dupuis J, Le Baleur Y, Belhadj K, Sobhani I, Haioun C, Bouvier AM, Delchier JC.

Leuk Lymphoma. 2017 Sep;58(9):1-11. doi: 10.1080/10428194.2017.1283033. Epub 2017 Jan 31.

PMID:
28140708
5.

Rescue therapy with bismuth-containing quadruple therapy in patients infected with metronidazole-resistant Helicobacter pylori strains.

Muller N, Amiot A, Le Thuaut A, Bastuji-Garin S, Deforges L, Delchier JC.

Clin Res Hepatol Gastroenterol. 2016 Sep;40(4):517-24. doi: 10.1016/j.clinre.2015.12.012. Epub 2016 Feb 2.

PMID:
26850363
6.

Therapeutic drug monitoring is predictive of loss of response after de-escalation of infliximab therapy in patients with inflammatory bowel disease in clinical remission.

Amiot A, Hulin A, Belhassan M, Andre C, Gagniere C, Le Baleur Y, Farcet JP, Delchier JC, Hüe S.

Clin Res Hepatol Gastroenterol. 2016 Feb;40(1):90-8. doi: 10.1016/j.clinre.2015.05.019. Epub 2015 Jun 29.

PMID:
26138132
7.

Endoscopic transgastric versus surgical necrosectomy in infected pancreatic necrosis.

Tan V, Charachon A, Lescot T, Chafaï N, Le Baleur Y, Delchier JC, Paye F.

Clin Res Hepatol Gastroenterol. 2014 Dec;38(6):770-6. doi: 10.1016/j.clinre.2014.06.016. Epub 2014 Aug 19.

PMID:
25153999
8.

Letter: Bismuth quadruple therapy with Pylera for Helicobacter pylori infection--authors' reply.

Malfertheiner P, Delchier JC.

Aliment Pharmacol Ther. 2014 Sep;40(6):736-7. doi: 10.1111/apt.12909. No abstract available.

9.

The detection of the methylated Wif-1 gene is more accurate than a fecal occult blood test for colorectal cancer screening.

Amiot A, Mansour H, Baumgaertner I, Delchier JC, Tournigand C, Furet JP, Carrau JP, Canoui-Poitrine F, Sobhani I; CRC group of Val De Marne.

PLoS One. 2014 Jul 15;9(7):e99233. doi: 10.1371/journal.pone.0099233. eCollection 2014.

10.

Infliximab as a bridge to remission maintained by antimetabolite therapy in Crohn's disease: A retrospective study.

Chauvin A, Le Thuaut A, Belhassan M, Le Baleur Y, Mesli F, Bastuji-Garin S, Delchier JC, Amiot A.

Dig Liver Dis. 2014 Aug;46(8):695-700. doi: 10.1016/j.dld.2014.04.012. Epub 2014 Jun 2.

PMID:
24893686
11.

Use of a combination formulation of bismuth, metronidazole and tetracycline with omeprazole as a rescue therapy for eradication of Helicobacter pylori.

Delchier JC, Malfertheiner P, Thieroff-Ekerdt R.

Aliment Pharmacol Ther. 2014 Jul;40(2):171-7. doi: 10.1111/apt.12808. Epub 2014 May 25.

12.

[MALT lymphoma].

Delchier JC.

Rev Prat. 2014 Feb;64(2):199-200. French. No abstract available.

PMID:
24701885
13.

[Natural history of gastric cancer linked to Helicobacter pylori].

Delchier JC.

Rev Prat. 2014 Feb;64(2):195-8. French.

PMID:
24701884
14.

[Prevent the dreaded gastric cancer].

Delchier JC.

Rev Prat. 2014 Feb;64(2):187-8. French. No abstract available.

PMID:
24701882
15.

Rituximab, alkylating agents or combination therapy for gastric mucosa-associated lymphoid tissue lymphoma: a monocentric non-randomised observational study.

Amiot A, Lévy M, Copie-Bergman C, Dupuis J, Szablewski V, Le Baleur Y, Baia M, Belhadj K, Sobhani I, Leroy K, Haioun C, Delchier JC.

Aliment Pharmacol Ther. 2014 Mar;39(6):619-28. doi: 10.1111/apt.12635. Epub 2014 Jan 27.

16.

Microbial dysbiosis and colon carcinogenesis: could colon cancer be considered a bacteria-related disease?

Sobhani I, Amiot A, Le Baleur Y, Levy M, Auriault ML, Van Nhieu JT, Delchier JC.

Therap Adv Gastroenterol. 2013 May;6(3):215-29. doi: 10.1177/1756283X12473674.

17.

Comparative evaluation of 29 commercial Helicobacter pylori serological kits.

Burucoa C, Delchier JC, Courillon-Mallet A, de Korwin JD, Mégraud F, Zerbib F, Raymond J, Fauchère JL.

Helicobacter. 2013 Jun;18(3):169-79. doi: 10.1111/hel.12030. Epub 2013 Jan 14.

PMID:
23316886
18.

Infliximab infusion time in patients with inflammatory bowel diseases: is longer really safer?

Belhassan M, Zeitoun JD, Lefevre JH, Charachon A, Amiot A, Le Baleur Y, Sobhani I, Delchier JC.

Clin Res Hepatol Gastroenterol. 2013 Apr;37(2):189-92. doi: 10.1016/j.clinre.2012.07.004. Epub 2012 Dec 12.

PMID:
23246140
19.

Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial.

Laharie D, Bourreille A, Branche J, Allez M, Bouhnik Y, Filippi J, Zerbib F, Savoye G, Nachury M, Moreau J, Delchier JC, Cosnes J, Ricart E, Dewit O, Lopez-Sanroman A, Dupas JL, Carbonnel F, Bommelaer G, Coffin B, Roblin X, Van Assche G, Esteve M, Färkkilä M, Gisbert JP, Marteau P, Nahon S, de Vos M, Franchimont D, Mary JY, Colombel JF, Lémann M; Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.

Lancet. 2012 Dec 1;380(9857):1909-15. doi: 10.1016/S0140-6736(12)61084-8. Epub 2012 Oct 10.

PMID:
23063316
20.

Rituximab and chlorambucil versus rituximab alone in gastric mucosa-associated lymphoid tissue lymphoma according to t(11;18) status: a monocentric non-randomized observational study.

Lévy M, Copie-Bergman C, Amiot A, Dupuis J, Le Baleur Y, Belhadj K, Hémery F, Sobhani I, Delfau-Larue MH, Leroy K, Haioun C, Delchier JC.

Leuk Lymphoma. 2013 May;54(5):940-4. doi: 10.3109/10428194.2012.729832. Epub 2012 Oct 4.

PMID:
22978684
21.

Is elevated gastric tissue NOX2 associated with lymphoma of mucosa-associated lymphoid tissue?

Bessède E, Copie-Bergman C, Lehours P, Levy M, Leroy K, Baia M, Riou A, Mégraud F, Delchier JC, Salles N.

Antioxid Redox Signal. 2012 Jun 1;16(11):1205-11. doi: 10.1089/ars.2011.4494. Epub 2012 Mar 15.

22.

First detection of Helicobacter canis in chronic duodenal ulcerations from a patient with Crohn's disease.

Tankovic J, Smati M, Lamarque D, Delchier JC.

Inflamm Bowel Dis. 2011 Aug;17(8):1830-1. doi: 10.1002/ibd.21610. Epub 2011 Jan 13. No abstract available.

PMID:
21744440
23.

Low prevalence of colonoscopic surveillance of inflammatory bowel disease patients with longstanding extensive colitis: a clinical practice survey nested in the CESAME cohort.

Vienne A, Simon T, Cosnes J, Baudry C, Bouhnik Y, Soulé JC, Chaussade S, Marteau P, Jian R, Delchier JC, Coffin B, Admane H, Carrat F, Drouet E, Beaugerie L.

Aliment Pharmacol Ther. 2011 Jul;34(2):188-95. doi: 10.1111/j.1365-2036.2011.04711.x. Epub 2011 May 27.

24.

[HNPCC (hereditary non-polyposis colorectal cancer) or Lynch syndrome: a syndrome related to a failure of DNA repair system].

Manceau G, Karoui M, Charachon A, Delchier JC, Sobhani I.

Bull Cancer. 2011 Mar;98(3):323-36. doi: 10.1684/bdc.2011.1328. Review. French.

25.

Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial.

Malfertheiner P, Bazzoli F, Delchier JC, Celiñski K, Giguère M, Rivière M, Mégraud F; Pylera Study Group.

Lancet. 2011 Mar 12;377(9769):905-13. doi: 10.1016/S0140-6736(11)60020-2. Epub 2011 Feb 21. Erratum in: Lancet. 2011 Nov 19;378(9805):1778. Dosage error in article text.

PMID:
21345487
26.

From array-based hybridization of Helicobacter pylori isolates to the complete genome sequence of an isolate associated with MALT lymphoma.

Thiberge JM, Boursaux-Eude C, Lehours P, Dillies MA, Creno S, Coppée JY, Rouy Z, Lajus A, Ma L, Burucoa C, Ruskoné-Foumestraux A, Courillon-Mallet A, De Reuse H, Boneca IG, Lamarque D, Mégraud F, Delchier JC, Médigue C, Bouchier C, Labigne A, Raymond J.

BMC Genomics. 2010 Jun 10;11:368. doi: 10.1186/1471-2164-11-368.

27.

CYP2C9*3 Loss-of-Function Allele Is Associated With Acute Upper Gastrointestinal Bleeding Related to the Use of NSAIDs Other Than Aspirin.

Carbonell N, Verstuyft C, Massard J, Letierce A, Cellier C, Deforges L, Saliba F, Delchier JC, Becquemont L.

Clin Pharmacol Ther. 2010 Jun;87(6):693-8. doi: 10.1038/clpt.2010.33. Epub 2010 May 5.

PMID:
20445534
28.

Development of diffuse psoriasis with alopecia during treatment of Crohn's disease with infliximab.

Medkour F, Babai S, Chanteloup E, Buffard V, Delchier JC, Le-Louet H.

Gastroenterol Clin Biol. 2010 Feb;34(2):140-1. doi: 10.1016/j.gcb.2009.10.021. Epub 2010 Feb 6. No abstract available.

29.

Treatment of t(11;18)-positive gastric mucosa-associated lymphoid tissue lymphoma with rituximab and chlorambucil: clinical, histological, and molecular follow-up.

Lévy M, Copie-Bergman C, Molinier-Frenkel V, Riou A, Haioun C, Gaulard P, Delfau-Larue MH, Sobhani I, Leroy K, Delchier JC.

Leuk Lymphoma. 2010 Feb;51(2):284-90. doi: 10.3109/10428190903431820.

PMID:
20038225
30.

Complete remission of gastric Burkitt's lymphoma after eradication of Helicobacter pylori.

Baumgaertner I, Copie-Bergman C, Levy M, Haioun C, Charachon A, Baia M, Sobhani I, Delchier JC.

World J Gastroenterol. 2009 Dec 7;15(45):5746-50.

31.

You cannot see the wood for the tree.

Dhooge M, Zeitoun JD, Tayar C, Kobeiter H, Lesprit P, Delchier JC, Charachon A.

Am J Gastroenterol. 2009 Oct;104(10):2636-7. doi: 10.1038/ajg.2009.323. No abstract available.

PMID:
19806103
32.

Evaluation of a new test, genotype HelicoDR, for molecular detection of antibiotic resistance in Helicobacter pylori.

Cambau E, Allerheiligen V, Coulon C, Corbel C, Lascols C, Deforges L, Soussy CJ, Delchier JC, Megraud F.

J Clin Microbiol. 2009 Nov;47(11):3600-7. doi: 10.1128/JCM.00744-09. Epub 2009 Sep 16.

33.

Self-expanding metallic stent for ischemic colonic obstruction.

Zeitoun JD, Van Nhieu JT, Brunetti F, Luciani A, Karoui M, Delchier JC, Charachon A.

Am J Gastroenterol. 2009 Sep;104(9):2372-3. doi: 10.1038/ajg.2009.309. No abstract available.

PMID:
19727109
34.

Helicobacter pylori and non-malignant diseases.

Furuta T, Delchier JC.

Helicobacter. 2009 Sep;14 Suppl 1:29-35. doi: 10.1111/j.1523-5378.2009.00697.x. Review.

PMID:
19712165
35.

Proteomic Helicobacter pylori biomarkers discriminative of low-grade gastric MALT lymphoma and duodenal ulcer.

Bernarde C, Khoder G, Lehours P, Burucoa C, Fauchère JL, Delchier JC, Mégraud F, Atanassov C.

Proteomics Clin Appl. 2009 Jun;3(6):672-81. doi: 10.1002/prca.200800158.

PMID:
21136979
36.

Chlorambucil versus observation after anti-Helicobacter therapy in gastric MALT lymphomas: results of the international randomised LY03 trial.

Hancock BW, Qian W, Linch D, Delchier JC, Smith P, Jakupovic I, Burton C, Souhami R, Wotherspoon A, Copie-Bergman C, Capella C, Traulle C, Levy M, Cortelazzo S, Ferreri AJ, Ambrosetti A, Pinotti G, Martinelli G, Vitolo U, Cavalli F, Gisselbrecht C, Zucca E.

Br J Haematol. 2009 Feb;144(3):367-75. doi: 10.1111/j.1365-2141.2008.07486.x. Epub 2008 Nov 22.

37.

Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II.

Malamut G, Afchain P, Verkarre V, Lecomte T, Amiot A, Damotte D, Bouhnik Y, Colombel JF, Delchier JC, Allez M, Cosnes J, Lavergne-Slove A, Meresse B, Trinquart L, Macintyre E, Radford-Weiss I, Hermine O, Brousse N, Cerf-Bensussan N, Cellier C.

Gastroenterology. 2009 Jan;136(1):81-90. doi: 10.1053/j.gastro.2008.09.069. Epub 2008 Oct 7.

PMID:
19014942
38.

Leptin receptor-related immune response in colorectal tumors: the role of colonocytes and interleukin-8.

Abolhassani M, Aloulou N, Chaumette MT, Aparicio T, Martin-Garcia N, Mansour H, Le Gouvello S, Delchier JC, Sobhani I.

Cancer Res. 2008 Nov 15;68(22):9423-32. doi: 10.1158/0008-5472.CAN-08-1017.

39.

[Helicobacter pylori infection: what to do after first intent treatment failure?].

Delchier JC.

Rev Prat. 2008 Sep 15;58(13):1442-4. French.

PMID:
18924328
40.

Fixed-dose rate gemcitabine in elderly patients with advanced pancreatic cancer: an observational study.

Locher C, Fabre-Guillevin E, Brunetti F, Auroux J, Delchier JC, Piedbois P, Zelek L.

Crit Rev Oncol Hematol. 2008 Nov;68(2):178-82. doi: 10.1016/j.critrevonc.2008.06.010. Epub 2008 Jul 30.

PMID:
18672379
41.

Primary hepatic lymphoma of mucosa-associated lymphoid tissue type: a case report with cytogenetic study.

Koubaa Mahjoub W, Chaumette-Planckaert MT, Murga Penas EM, Dierlamm J, Leroy K, Delfau MH, Loriau J, Gaulard P, Delchier JC, Zafrani ES, Copie-Bergman C.

Int J Surg Pathol. 2008 Jul;16(3):301-7. doi: 10.1177/1066896907312671. Epub 2008 Apr 2.

PMID:
18387997
42.

[Gastrointestinal manifestations of Helicobacter pylori infection in adults: from gastritis to gastric cancer].

Delchier JC.

Presse Med. 2008 Mar;37(3 Pt 2):519-24. doi: 10.1016/j.lpm.2007.07.031. Epub 2008 Feb 7. Review. French.

PMID:
18261873
43.

Routine use of real-time PCR for detection of Helicobacter pylori and of clarithromycin resistance mutations.

Tankovic J, Chaumette-Planckaert MT, Deforges L, Launay N, Le Glaunec JM, Soussy CJ, Delchier JC.

Gastroenterol Clin Biol. 2007 Oct;31(10):792-5.

44.

Stents for palliation of obstructive metastatic colon cancer: impact on management and chemotherapy administration.

Karoui M, Charachon A, Delbaldo C, Loriau J, Laurent A, Sobhani I, Tran Van Nhieu J, Delchier JC, Fagniez PL, Piedbois P, Cherqui D.

Arch Surg. 2007 Jul;142(7):619-23; discussion 623.

PMID:
17638798
45.

Genetic diversity of the HpyC1I restriction modification system in Helicobacter pylori.

Lehours P, Dupouy S, Chaineux J, Ruskoné-Fourmestraux A, Delchier JC, Morgner A, Mégraud F, Ménard A.

Res Microbiol. 2007 Apr;158(3):265-71. Epub 2007 Jan 13.

PMID:
17346936
46.

Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility.

Cattoir V, Nectoux J, Lascols C, Deforges L, Delchier JC, Megraud F, Soussy CJ, Cambau E.

Int J Antimicrob Agents. 2007 Apr;29(4):389-96. Epub 2007 Feb 15.

PMID:
17303392
47.

[Recommendations for the management of Helicobacter pylori infection according to Maastricht 3 guidelines].

Delchier JC.

Gastroenterol Clin Biol. 2006 Dec;30(12):1361-4. French. No abstract available.

48.

Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists.

Hamdi H, Mariette X, Godot V, Weldingh K, Hamid AM, Prejean MV, Baron G, Lemann M, Puechal X, Breban M, Berenbaum F, Delchier JC, Flipo RM, Dautzenberg B, Salmon D, Humbert M, Emilie D; RATIO (Recherche sur Anti-TNF et Infections Opportunistes) Study Group.

Arthritis Res Ther. 2006;8(4):R114.

49.

Frequent and rapid progression of atrophy and intestinal metaplasia in gastric mucosa of patients with MALT lymphoma.

Lamarque D, Levy M, Chaumette MT, Roudot-Thoraval F, Cavicchi M, Auroux J, Courillon-Mallet A, Haioun C, Delchier JC.

Am J Gastroenterol. 2006 Aug;101(8):1886-93. Epub 2006 Jun 16.

PMID:
16780555
50.

Infliximab plus azathioprine for steroid-dependent Crohn's disease patients: a randomized placebo-controlled trial.

Lémann M, Mary JY, Duclos B, Veyrac M, Dupas JL, Delchier JC, Laharie D, Moreau J, Cadiot G, Picon L, Bourreille A, Sobahni I, Colombel JF; Groupe d'Etude Therapeutique des Affections Inflammatoires du Tube Digestif (GETAID).

Gastroenterology. 2006 Apr;130(4):1054-61.

PMID:
16618399

Supplemental Content

Loading ...
Support Center